5th Floor, Rajapushpa Summit
Nanakramguda Rd, Financial District, Gachibowli
Hyderabad, Telangana - 500008
The France Diagnostic Imaging Market is segmented by Modality (MRI, Computed Tomography, Ultrasound, X-Ray, Nuclear Imaging, Fluoroscopy, and Mammography), Application and End User
2018 - 2026
The France Diagnostic Imaging market is anticipated to expand at a CAGR of 5.1% during the forecast period. The certain factors that are driving the market growth include the rising prevalence of chronic diseases, the growing adoption of advanced technologies in medical imaging, and an increase in the geriatric population.
The geriatric population is more prone to chronic diseases. According to the World Ageing 2019 report, estimated that in 2019 there were about 13.281 million (20.4%) population aged 65 years or over in France. This number is projected to reach 16.094 million (24.1%) in 2030. Therefore as the number of the elderly population is expected to increase in near future and this population is more prone to chronic conditions such as cardiovascular, musculoskeletal, and other diseases which will show a positive impact on the market and this will help to increase diagnostic procedures in the management of the disease.
Furthermore, the emergence of automated diagnostic imaging scanners and on-going R&D development in diagnostic imaging is also expected to propel the market growth. Thus, owing to above mentioned factors it is expected to show singificant growth over the forecast period.
As per the scope of the report, diagnostic imaging is the process of making a visual representation of the interior of a body for medical intervention. These equipment help in establishing a database of normal anatomy and physiology of internal organs, so that any abnormality can be noticed immediately. The ability to create pictures of a patient’s internal anatomy and convert them to film through diagnostic imaging has revolutionized the way many diseases and injuries are detected, diagnosed, and treated. It has a vast range of applications in a variety of oncological, orthopedic, gastro-, and gynecological fields.
Report scope can be customized per your requirements. Click here.
Cancer is one of the leading causes of morbidity and mortality in France. According to the Santé publique France and the French National Cancer Institute, the number of cancer cases has been increased at significant rates during 1990-2018. In 1990, there were 215,000 cases of cancer reported, which had increased to 382,000 by the end of 2018. The new cancer cases have increased by 65% in men and 93% in women.
In 2019, Hitachi, Ltd and Centre Léon Bérard (CLB) has entered into an agreement to promote research and development aimed at improving the efficiency of diagnosis and treatment of cancer and established a new research laboratory called Hitachi Lyon Lab. In this collaboration, Hitachi and Centre Léon Bérard (CLB) will conduct research and development of novel technologies to detect and diagnose cancers exploiting medical images such as CT/MRI using artificial intelligence (AI). Thus, increasing cases of cancer along with the development of novel diagnostic procedures is expected to drive market growth in the near future.
To understand key trends, Download Sample Report
The France Diagnostic Imaging Market is consolidated competitive owing to the presence of a few major players in the market. The market players are focusing on R&D to develop the technologically advanced products in order to reduce the cost and side effects associated with the products. Some of the market players are Koninklijke Philips N.V., Siemens Healthineers, FUJIFILM Holdings Corporation, GE Healthcare, Hitachi Medical Systems, Canon Medical Systems Corporation and others.
1.1 Study Assumptions
1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rise in the Prevalence of Chronic Diseases and Increase in the Geriatric Population
4.2.2 Increased Adoption of Advanced Technologies in Medical Imaging
4.3 Market Restraints
4.3.1 Side Effects of Diagnostic Imaging
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
5.1 By Modality
5.1.2 Computed Tomography
5.1.5 Nuclear Imaging
5.2 By Application
5.2.7 Other Applications
5.3 By End-User
5.3.2 Diagnostic Centers
5.3.3 Other End-Users
6. COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Koninklijke Philips N.V.
6.1.2 Siemens Healthineers
6.1.3 FUJIFILM Holdings Corporation
6.1.4 GE Healthcare
6.1.5 Hitachi Medical Systems
6.1.6 Canon Medical Systems Corporation
6.1.7 Hologic Corporation
6.1.8 Shimadzu Medical
6.1.9 Carestream Health Inc.
6.1.10 Esaote SpA
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments